News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011
News Daily News Researchers Accurately Predict Who Will Discontinue Clopidogrel Jason Kahn January 09, 2011
CME Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes